Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
35.95 (1y: +22%)
Market Cap 2.15 B P/E(ttm) 20.20
Enterprise Value 2.46 B P/B 2.70
HRC- NYSE (USA)
Hill-Rom Holdings, Inc.
  • Currently 1/5
Business Predictability Rank: 1-Star
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$35.95
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry		 vs
history
Cash to Debt 0.239
HRC's Cash to Debt is ranked lower than
82% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.43 vs. HRC: 0.239 )
HRC' s 10-Year Cash to Debt Range
Min: 0.23   Max: 1.49
Current: 0.24
0.23
1.49
Equity to Asset 0.115
HRC's Equity to Asset is ranked lower than
77% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.47 vs. HRC: 0.115 )
HRC' s 10-Year Equity to Asset Range
Min: 0.12   Max: 0.41
Current: 0.12
0.12
0.41
Interest Coverage 26
HRC's Interest Coverage is ranked lower than
58% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 46.10 vs. HRC: 26 )
HRC' s 10-Year Interest Coverage Range
Min: 7   Max: 26
Current: 26
7
26
F-Score: 5
Z-Score: 4.45
M-Score: -2.66
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry		 vs
history
Operating margin (%) 10.30
HRC's Operating margin (%) is ranked higher than
56% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.00 vs. HRC: 10.30 )
HRC' s 10-Year Operating margin (%) Range
Min: -27.6   Max: 17.5
Current: 10.3
-27.6
17.5
Net-margin (%) 7.4
HRC's Net-margin (%) is ranked higher than
59% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.30 vs. HRC: 7.4 )
HRC' s 10-Year Net-margin (%) Range
Min: -29.2   Max: 11.3
Current: 7.4
-29.2
11.3
ROE (%) 14.9
HRC's ROE (%) is ranked higher than
74% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. HRC: 14.9 )
HRC' s 10-Year ROE (%) Range
Min: -66.5   Max: 19.5
Current: 14.9
-66.5
19.5
ROA (%) 7.4
HRC's ROA (%) is ranked higher than
71% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. HRC: 7.4 )
HRC' s 10-Year ROA (%) Range
Min: -32.9   Max: 11.3
Current: 7.4
-32.9
11.3
ROC (Joel Greenblatt) (%) 28.90
HRC's ROC (Joel Greenblatt) (%) is ranked higher than
65% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 14.00 vs. HRC: 28.90 )
HRC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -72.4   Max: 75.1
Current: 28.9
-72.4
75.1
Revenue Growth (%) 4.3
HRC's Revenue Growth (%) is ranked higher than
64% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.40 vs. HRC: 4.3 )
HRC' s 10-Year Revenue Growth (%) Range
Min: -8.7   Max: 4.3
Current: 4.3
-8.7
4.3
ยป HRC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

HRC Guru Trades in Q2 2012

Paul Tudor Jones 6,900 sh (New)
Steven Cohen 21,510 sh (+132.16%)
Chuck Royce 600,170 sh (+35.33%)
Joel Greenblatt 111,514 sh (+28.31%)
John Keeley 1,420,877 sh (-0.21%)
Columbia Wanger 1,985,000 sh (-23.19%)
Jim Simons 240,300 sh (-32.42%)
» More
Q3 2012

HRC Guru Trades in Q3 2012

David Dreman 766,981 sh (New)
Ken Fisher 930,565 sh (New)
Joel Greenblatt 143,771 sh (+28.93%)
John Keeley 1,454,691 sh (+2.38%)
Steven Cohen Sold Out
Paul Tudor Jones Sold Out
Chuck Royce 515,770 sh (-14.06%)
Columbia Wanger 1,530,750 sh (-22.88%)
Jim Simons 156,000 sh (-35.08%)
» More
Q4 2012

HRC Guru Trades in Q4 2012

Chuck Royce 2,156,670 sh (+318.15%)
Ken Fisher 1,834,968 sh (+97.19%)
Jim Simons 298,400 sh (+91.28%)
Columbia Wanger Sold Out
John Keeley 1,440,595 sh (-0.97%)
David Dreman 759,334 sh (-1%)
Joel Greenblatt 63,553 sh (-55.8%)
» More
Q1 2013

HRC Guru Trades in Q1 2013

Chuck Royce 2,236,270 sh (+3.69%)
John Keeley 1,453,810 sh (+0.92%)
Ken Fisher 1,829,334 sh (-0.31%)
David Dreman 736,089 sh (-3.06%)
Joel Greenblatt 53,631 sh (-15.61%)
Jim Simons 185,200 sh (-37.94%)
» More
» Details

Insider Trades

Latest Guru Trades with HRC

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2012-12-31 Reduce -55.8%0.16%$26.4 - $30.56 $ 37.1131%63553
David Dreman 2012-09-30 New Buy0.56%$25.36 - $32.15 $ 37.1128%766981
Joel Greenblatt 2012-09-30 Add 28.93%0.06%$25.36 - $32.15 $ 37.1128%143771
Joel Greenblatt 2012-06-30 Add 28.31%0.06%$28.41 - $33.95 $ 37.1119%111514
Joel Greenblatt 2012-03-31 Add 159.59%0.15%$29.82 - $35.96 $ 37.1117%86913
Ray Dalio 2011-12-31 Sold Out 0.0031%$29.33 - $35 $ 37.1115%0
Joel Greenblatt 2011-09-30 Add 63.4%0.06%$27.37 - $47.48 $ 37.117%32068
Ray Dalio 2011-09-30 New Buy$27.37 - $47.48 $ 37.118%7023
Joel Greenblatt 2011-06-30 New Buy0.13%$38.54 - $46.45 $ 37.11-15%19625
George Soros 2011-06-30 Sold Out $38.54 - $46.45 $ 37.11-15%0
George Soros 2011-03-31 New Buy0.01%$35.4 - $41.39 $ 37.11-4%14400
George Soros 2010-09-30 Sold Out 0.01%$28.65 - $35.76 $ 37.1113%0
George Soros 2010-06-30 New Buy0.01%$27.43 - $32.76 $ 37.1123%12700
Premium More recent guru trades are included for Premium Members only!!

Ratios

vs
industry		 vs
history
P/E(ttm) 20.20
HRC's P/E(ttm) is ranked higher than
76% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.40 vs. HRC: 20.20 )
HRC' s 10-Year P/E(ttm) Range
Min: 7.22   Max: 36.87
Current: 20.2
7.22
36.87
P/B 2.70
HRC's P/B is ranked lower than
53% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.41 vs. HRC: 2.70 )
HRC' s 10-Year P/B Range
Min: 0.58   Max: 4.04
Current: 2.7
0.58
4.04
P/S 1.30
HRC's P/S is ranked higher than
72% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. HRC: 1.30 )
HRC' s 10-Year P/S Range
Min: 0.4   Max: 1.95
Current: 1.3
0.4
1.95
PFCF 12.10
HRC's PFCF is ranked higher than
84% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.35 vs. HRC: 12.10 )
HRC' s 10-Year PFCF Range
Min: 1.54   Max: 103.38
Current: 12.1
1.54
103.38
EV-to-EBIT 15.6
HRC's EV-to-EBIT is ranked higher than
72% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.12 vs. HRC: 15.6 )
HRC' s 10-Year EV-to-EBIT Range
Min: 5.1   Max: 16.5
Current: 15.6
5.1
16.5
Shiller P/E 53.9
HRC's Shiller P/E is ranked higher than
64% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.85 vs. HRC: 53.9 )
HRC' s 10-Year Shiller P/E Range
Min: 5.01   Max: 205.83
Current: 53.9
5.01
205.83

Dividend & Buy Back

vs
industry		 vs
history
Dividend Yield 1.40
HRC's Dividend Yield is ranked higher than
77% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.55 vs. HRC: 1.40 )
HRC' s 10-Year Dividend Yield Range
Min: 0.89   Max: 6.05
Current: 1.4
0.89
6.05
Dividend Payout 0.2827
HRC's Dividend Payout is ranked higher than
88% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.53 vs. HRC: 0.2827 )
HRC' s 10-Year Dividend Payout Range
Min: 0.21   Max: 0.62
Current: 0.28
0.21
0.62
Dividend growth (3y) 4.5
HRC's Dividend growth (3y) is ranked higher than
92% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.50 vs. HRC: 4.5 )
HRC' s 10-Year Dividend growth (3y) Range
Min: -22.5   Max: 7.8
Current: 4.5
-22.5
7.8
Yield on cost (5-Year) 0.90
HRC's Yield on cost (5-Year) is ranked higher than
69% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.66 vs. HRC: 0.90 )
HRC' s 10-Year Yield on cost (5-Year) Range
Min: 0.57   Max: 3.9
Current: 0.9
0.57
3.9
Share Buyback Rate 0.1
HRC's Share Buyback Rate is ranked higher than
82% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -1.70 vs. HRC: 0.1 )
HRC' s 10-Year Share Buyback Rate Range
Min: 1.8   Max: -0.6
Current: 0.1

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 6.3
HRC's Price/Net Current Asset Value is ranked lower than
56% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.40 vs. HRC: 6.3 )
HRC' s 10-Year Price/Net Current Asset Value Range
Min: 4.1   Max: 7.6
Current: 6.3
4.1
7.6
Price/Tangible Book 11.6
HRC's Price/Tangible Book is ranked higher than
87% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. HRC: 11.6 )
HRC' s 10-Year Price/Tangible Book Range
Min: 1.9   Max: 9.7
Current: 11.6
1.9
9.7
Price/DCF (Projected) 1
HRC's Price/DCF (Projected) is ranked higher than
71% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.20 vs. HRC: 1 )
HRC' s 10-Year Price/DCF (Projected) Range
Min: 0.6   Max: 1.4
Current: 1
0.6
1.4
Price/Median PS Value 1.4
HRC's Price/Median PS Value is ranked higher than
81% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.90 vs. HRC: 1.4 )
HRC' s 10-Year Price/Median PS Value Range
Min: 0.8   Max: 1.6
Current: 1.4
0.8
1.6
Price/Graham Number 3.1
HRC's Price/Graham Number is ranked higher than
86% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.30 vs. HRC: 3.1 )
HRC' s 10-Year Price/Graham Number Range
Min: 0.9   Max: 2.5
Current: 3.1
0.9
2.5
Earnings Yield (Greenblatt) 6.40
HRC's Earnings Yield (Greenblatt) is ranked higher than
82% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. HRC: 6.40 )
HRC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 6   Max: 19.8
Current: 6.4
6
19.8
Forward Rate of Return (Yacktman) 5.62
HRC's Forward Rate of Return (Yacktman) is ranked higher than
69% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.11 vs. HRC: 5.62 )
HRC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -6   Max: 27
Current: 5.62
-6
27

Business Description

Hill-Rom Holdings, Inc. formerly known as Hillenbrand Industries, Inc. was incorporated on August 7, 1969 in the State of Indiana. The Company is a worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals and information technology solutions. The Company's comprehensive product and service offerings are used by health care providers across the health care continuum in hospitals, extended care facilities and home care settings worldwide, to enhance the safety and quality of patient care. The company operates in three segments namely North America, Surgical and Respiratory Care and International. The Company's innovative patient support systems include a variety of electrically adjustable and manual bed systems and integrated and non-integrated therapeutic surfaces for use in high, mid and low acuity settings. Surgical table accessories from its Allen Medical business include the FlexFrame device, which converts a standard operating room table into a surgical table for spine procedures. It rents and sells non-invasive therapeutic products and surfaces for a variety of acute and chronic medical conditions, including pulmonary, wound and bariatric conditions, primarily to acute, extended and home care customers. It provides peak-need rentals and health care provider asset management for a wide variety of moveable medical equipment, also known as MME, such as ventilators defibrillators, intravenous pumps, and patient monitoring equipment. The products under Patient Environment and Mobilization Solutions include mobility solutions, architectural products and health care furniture. Architectural products include headwalls and power columns, such as the intensive care architectural arm platform called the Latitude system and the Elements headwall system, which both enable medical gases, communication accessories and electrical services to be distributed in patient rooms. It develops and markets a variety of communications technologies and software solutions that are designed to improve patient safety, drive efficiency at the point of care, and integrate the health care enterprise. These products include its suite of clinical communication and productivity solutions, its NaviCare platform, patient safety and its NaviCare Nurse Call. Principal materials used in its products include carbon steel, aluminum, stainless steel, wood and laminates, petroleum based products, such as foams and plastics, and other materials. It delivers its products to customers through international service centers. Some of the competitors are Invacare Corporation, Stryker Corporation, Encompass Group, LLC, Span-America Medical Systems, Inc., Dukane Corporation etc. The Company designs, manufactures, installs and distributes me
Company Website
SEC Reports
Industry: Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO
ยป More Articles for HRC

Headlines

Articles On GuruFocus.com
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 21,029 Shares Dec 07 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 18,893 Shares Dec 03 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 20,005 Shares Nov 23 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 9,757 Shares Nov 16 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 33,670 Shares Nov 12 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 25,967 Shares Nov 08 2010 
Weekly CEO Buys Highlight: AOL Inc, Consolidated Graphics Inc, Saul Centers Inc, Hill-ROM Holdings, May 16 2010 
HILL-ROM HOLDINGS, INC. (HRC) CEO John J Greisch buys 30,000 Shares May 12 2010 
HILL-ROM HOLDINGS, INC. Reports Operating Results (10-Q) Feb 04 2010 
HILL ROM HOLDINGS INC Reports Operating Results (10-Q) May 05 2009 

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial